Josh Riggs - 28 Sep 2025 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (OCX)

Role
CEO and President, Director
Signature
/s/ Josh Riggs
Issuer symbol
OCX
Transactions as of
28 Sep 2025
Net transactions value
$0
Form type
4
Filing time
30 Sep 2025, 16:05:30 UTC
Previous filing
28 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Riggs Josh CEO and President, Director C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE /s/ Josh Riggs 30 Sep 2025 0001956391

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMDX Option to Purchase Common Stock Award $0 +400,000 $0.000000 400,000 28 Sep 2025 Common Stock 400,000 $3.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.